Explore the strengths and limitations of how studies of similar phenomena differ in interpretation and presentation.

Explore the strengths and limitations of how studies of similar phenomena differ in interpretation and presentation.

This assignment will allow you to explore and understand the strengths and limitations of how studies of similar phenomena differ in interpretation and presentation.

Using the South University Online Library, access and review the following two articles of opposing conclusions:

Mikovits, J. A., Lombardi, V. C., Pfost, M. A., Hagen, K. S., & Ruscetti, F. W.

(2010). Detection of an infectious retrovirus, XMRV, in blood cells of patients with

chronic fatigue syndrome. Virulence, 1(5), 386–390.

Shin, C. H., Bateman, L., Schlaberg, R., Bunker, A. M., Leonard, C. J., Hughen,

R. W., . . . Singh, I. R. (2011). Absence of XMRV retrovirus and other

murine leukemia virus-related viruses in patients with chronic fatigue

syndrome. Journal of Virology. 85(14), 7195–7202.

In a Microsoft Word document, write a 1-page assessment of each study design and results. In your assessment:

Compare the merits of each approach.
On the basis of your readings and knowledge of epidemiology to date, provide an analysis of the results and indicate which study (if any) is more credible and why.
Determine whether you support the results and discuss any suggestions, observations, or recommendations you may have for supporting or disputing how the results were presented.


 

smilesmile. .

get-your-custom-paper






The post Explore the strengths and limitations of how studies of similar phenomena differ in interpretation and presentation. appeared first on My Nursing Paper.

 
Do you need a similar assignment done for you from scratch? We have qualified writers to help you. We assure you an A+ quality paper that is free from plagiarism. Order now for an Amazing Discount!
Use Discount Code "Newclient" for a 15% Discount!

NB: We do not resell papers. Upon ordering, we do an original paper exclusively for you.